Keyphrases
Leucine-rich Repeat Kinase 2 (LRRK2)
100%
GBA1
100%
Parkinson's Disease
100%
Disease Pathogenesis
16%
Genetic Studies
16%
Kinase Inhibitor
16%
Glucocerebrosidase
16%
Mutation Carriers
8%
Sporadic Cases
8%
Familial Cases
8%
Age of Onset
8%
Human Dopaminergic Neuron
8%
G2019S mutation
8%
Causal Genes
8%
Disease Symptoms
8%
Targeted Therapy
8%
Genetic Risk
8%
Biological Pathways
8%
Mutant Mouse Models
8%
Mutation Effect
8%
Synergistic Effect
8%
Disease-causing mutations
8%
Induced Pluripotent Stem Cells (iPSCs)
8%
Risk Genes
8%
Therapeutic Efficacy
8%
GBA mutations
8%
Biochemistry, Genetics and Molecular Biology
Leucine-Rich Repeat
100%
Kinase
100%
Phosphotransferase
100%
Genetics
14%
Glucocerebrosidase
14%
Glucosylceramidase
14%
Mouse Model
7%
Genetic Risk
7%
Induced Pluripotent Stem Cell
7%
Mouse Mutant
7%
Dopaminergic
7%
Pharmacology, Toxicology and Pharmaceutical Science
Leucine Rich Repeat Kinase 2
100%
Parkinson's Disease
100%
Glucosylceramidase
16%
Phosphotransferase Inhibitor
16%
Mouse Model
8%
Dopamine Receptor Stimulating Agent
8%
Onset Age
8%
Genetic Risk
8%
Mouse Mutant
8%
Combination Therapy
8%
Diseases
8%